Related Experiment Video
Updated: Mar 3, 2026

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
Dual Plug-and-Display Synthetic Assembly Using Orthogonal Reactive Proteins for Twin Antigen Immunization
Karl D Brune1, Can M Buldun1, Yuanyuan Li2
1Department of Biochemistry, University of Oxford , South Parks Road, Oxford OX1 3QU, United Kingdom.
Scientists engineered a novel nanoparticle platform for vaccines, enabling the display of multiple antigens to enhance immune responses against diseases like malaria.
Area of Science:
- Biomolecular engineering
- Vaccine development
- Synthetic biology
Background:
- Modular platforms control biomolecular architecture for biological system manipulation.
- Current vaccines use single antigens; displaying multiple antigens on one particle is challenging for broader immunity.
- Icosahedral particles with single antigens are effective but limited in scope.
Purpose of the Study:
- To design a dually addressable synthetic nanoparticle platform for displaying multiple antigens.
- To overcome challenges in inducing broader immunity across strains or diseases.
- To accelerate vaccine development, particularly for malaria.
Main Methods:
- Engineered a nanoparticle using multimerizing coiled-coil IMX313 and two split proteins (SpyCatcher and SnoopCatcher).
- Utilized orthogonal protein ligation (SpyTag/SnoopTag) for spontaneous antigen attachment to opposite nanoparticle faces.
- Expressed the platform in Escherichia coli and tested its stability under various conditions.
Main Results:
- Demonstrated efficient derivatization with model proteins and pathogen-derived antigens.
- Confirmed the nanoparticle's resilience to lyophilization and extreme temperatures.
- Showed enhanced antibody response to malaria transmission-blocking antigens (Pfs25, Pfs28) when multimerized on the platform compared to monomers.
Conclusions:
- The SpyCatcher-IMX-SnoopCatcher platform offers a modular "plug-and-display" system for multivalent vaccines.
- This dual architecture facilitates the simultaneous display of multiple antigens, boosting immune responses.
- The platform shows promise for accelerating vaccine development for malaria and other infectious diseases.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
10:16Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
Published on: October 12, 2018
Related Concept Videos
Cross-reactivity
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...